- December 18, 2007
- Anthera receives orphan drug status for the prevention of acute chest syndrome in patients with sickle cell disease
- December 17, 2007
- Dynogen announces positive results in Phase 2 IBS-d study
- December 11, 2007
- FlowCardia launches peripheral CROSSER catheters in the US
- December 10, 2007
- MethylGene and Pharmion present favorable clinical data from combination MGCD0103/Vidaza® study
- December 9, 2007
- MethylGene and Pharmion report favorable results for Phase 2 single-agent studies in relapsed or refractory lymphomas
- November 15, 2007
- Athersys authorized for Phase 1 clinical trial in bone marrow transplant support
- November 14, 2007
- LEAD Therapeutics announces strategic research collaboration with ShangPharma
- November 8, 2007
- Dynogen begins Phase 2b trial for IBS with constipation drug
- November 5, 2007
- LEAD Therapeutics raises $17 million in Series A financing
- October 25, 2007
- Panacos announces greater than 1 Log10 mean reduction in 300 mg bevirimat cohort
- October 24, 2007
- Anthera announces positive Phase II clinical results from A-002 cardiovascular disease trial
- October 24, 2007
- MethylGene and Pharmion report preliminary clinical data at the 2007 AACR-NCI-EORTC International Conference
- October 15, 2007
- Dynogen announces the presentation of its positive Phase 1b trial results at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Philadelphia, PA
- October 9, 2007
- Optherion completes $37 million start up financing
- September 27, 2007
- BrainCells, Taisho Pharmaceutical, sign licensing agreement for novel CNS program
- August 30, 2007
- FlowCardia today announced it has raised $30 million in Series C financing
- August 20, 2007
- Methylgene and Pharmion announce collaboration to develop sirtuin inhibitors as anti-cancer agents
- July 30, 2007
- TargeGen initiates Phase II clinical trial of topically-applied drug for age-related macular degeneration
- July 25, 2007
- Athersys begins Phase I trial for ATHX-105 for treatment of obesity
- July 12, 2007
- TargeGen closes on $40 million venture round
- June 19, 2007
- Gentis announces the closing of its $10 million series a preferred financing and the first clinical use of its proprietary DiscCell spinal nucleus augmentation material
- June 11, 2007
- Athersys raises $65 million in concurrent reverse merger and private equity offering
- May 30, 2007
- Strategic partnership gives CeNeRx rights to develop and commercialize cannabinoid pipeline for pain and other disorders
- April 13, 2007
- Syndax Pharmaceuticals licenses selective histone deacetylase inhibitor MS-275
- April 3, 2007
- Syndax Pharmaceuticals closes $40 Million Series A Financing
- February 26, 2007
- Getting Closer to Nature: The BrainCells Way
- February 13, 2007
- Dynogen reports positive results in Phase 2 IBS-c study
- January 31, 2007
- CeNeRx BioPharma initiates human trials of RIMA antidepressant
- January 23, 2007
- FlowCardia, Inc. announces 510(k) clearance for its chronic total occlusion recanalization system
- January 4, 2007
- Biogen Idec to acquire Syntonix Pharmaceuticals